Summary: Researchers have identified a clear biological change in the brains of people with Long COVID who experience brain fog and cognitive decline: the small blood vessels in the brain show reduced integrity and increased “leakiness.” Using a newly developed MRI method, the team objectively distinguished patients with neurological symptoms from those without, offering a measurable marker that could guide diagnosis and future treatments.
The study links two interacting mechanisms—vascular disruption and an overactive immune response—as likely contributors to post-COVID cognitive symptoms. Funded through a rapid-response grant during the pandemic, this research provides fresh direction for targeted therapies and advances our understanding of how viral infections can cause persistent neurological conditions.
Key Facts:
- Blood vessel integrity is reduced: Patients with Long COVID who report brain fog and cognitive decline show evidence of blood vessel “leakiness” in the brain, suggesting a vascular component to their symptoms.
- New MRI technique: Investigators developed a specialized MRI approach that visualizes subtle changes in the brain’s vascular network, enabling an objective distinction between patients with and without neurological symptoms.
- Pathway to targeted therapy: The findings implicate both immune hyperactivity and vascular disruption as drivers of cognitive symptoms, pointing toward therapeutic strategies that address these specific mechanisms.
Source: TCD
Overview
A research team from Trinity College Dublin, working with investigators at FutureNeuro, has published new evidence showing that Long COVID-related brain fog correlates with measurable changes in the brain’s vascular system. The results, reported in the journal Nature Neuroscience, reveal that microvascular integrity is compromised in affected individuals, creating a biological basis for symptoms that have often been dismissed as subjective or hard to quantify.
Long COVID emerged after the global spread of SARS-CoV-2 in late 2019 and has since been associated with a wide range of persistent symptoms. Although most people recover fully from the acute infection, a significant minority experience ongoing issues beyond 12 weeks. Common complaints include fatigue, shortness of breath, joint and muscle pain, and cognitive problems such as memory loss, difficulty concentrating, and so-called brain fog.
Estimates vary by region, but Long COVID is believed to affect up to about 10% of people infected with SARS-CoV-2. Among those affected, nearly half report some form of lingering neurological symptom. Until now, objective biomarkers that correlate specifically with cognitive complaints have been limited.
The Trinity-led team applied a novel MRI protocol designed to detect subtle vascular changes and metabolic signals in the brain. Their scans detected increased permeability—“leakiness”—in the small vessels of patients with reported brain fog, compared with Long COVID patients who did not report cognitive complaints. This objective measure allows clinicians and researchers to differentiate subgroups within the broader Long COVID population based on detectable brain changes.
“For the first time, we have been able to show that leaky blood vessels in the human brain, together with a hyperactive immune response, may drive the brain fog seen after COVID-19,” said Professor Matthew Campbell, Head of Genetics at Trinity and Principal Investigator at FutureNeuro. “Understanding these underlying causes is essential for developing targeted therapies for patients going forward.”
The work was supported by a rapid-response grant from Science Foundation Ireland in 2020 and included patients recruited from the community as well as individuals hospitalized at St James’ Hospital. Conducting this complex clinical research during an intense phase of the pandemic required careful coordination and dedication from medical and research staff.
Professor Colin Doherty, Head of the School of Medicine at Trinity and a study co-leader, commented: “These results are likely to change the way we think about and treat post-viral neurological conditions. The neurological symptoms reported by Long COVID patients are accompanied by real, measurable metabolic and vascular changes in the brain.”
Broader implications
Beyond COVID-19, the research raises the possibility that other post-viral syndromes and certain neurological diseases may share similar vascular and immune-related mechanisms. Viral infections have long been suspected as triggers for conditions such as multiple sclerosis, but direct links have been difficult to demonstrate. By confirming that SARS-CoV-2 infection preceded Long COVID in every participant (through PCR-confirmed diagnoses recorded in Ireland), the team provides a clear example of a post-viral pathway that can be measured and studied further.
Dr. Chris Greene, the study’s first author and a postdoctoral research fellow, noted: “Our findings create a framework for additional research into the molecular events that lead to post-viral fatigue and brain fog. Similar processes may operate across different viral infections, and we are now closer to understanding why they produce neurological dysfunction in some patients.”
About this Long COVID and neurology research news
Author: Thomas Deane
Source: TCD
Contact: Thomas Deane – TCD
Image credit: Neuroscience News
Original Research: The full findings are published in Nature Neuroscience